Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Measuring the Effects of Continuous Dopaminergic Stimulation on Nocturnal Movements in Parkinson's Disease

This study has been terminated.
(difficulty to include enough subjects)
Sponsor:
Information provided by (Responsible Party):
D.A.A. Pevernagie, MD PhD, Sleep Medicine Centre Kempenhaeghe
ClinicalTrials.gov Identifier:
NCT01554306
First received: March 5, 2012
Last updated: October 28, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2014
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)